KPP
PAHC icon

Kings Path Partners’s Phibro Animal Health PAHC Stock Holding History

Kings Path Partners’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$539K Hold
17,155
– – 0.14% 63
2026
Q1 		$641K Hold
17,155
– – 0.22% 46
2025
Q4 		$641K Hold
17,155
– – 0.22% 46
2025
Q3 		$694K Sell
17,155
-3,445
-17% -$114K 0.26% 41
2025
Q2 		$526K Buy
20,600
+9,600
+87% +$209K 0.21% 55
2025
Q1 		$235K Buy
+11,000
New +$246K 0.12% 90

Other funds holding PAHC

HAI
Hennessy Advisors Inc Novato, California $3.13B AUM 77.26% 1-Year Est. Return
CCMINC
Cardinal Capital Management Inc (North Carolina) Raleigh, North Carolina $826M AUM 32.06% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
HFS
Hughes Financial Services Herndon, Virginia $755M AUM 20.43% 1-Year Est. Return
FMP
Financial Management Professionals Austin, Texas $1.05B AUM 21.07% 1-Year Est. Return
1IA
1620 Investment Advisors Plymouth, Massachusetts $161M AUM 30.15% 1-Year Est. Return

Kings Path Partners's PAHC Position: Q2 2026 in Review

Kings Path Partners held its Phibro Animal Health (PAHC) position steady in Q2 2026 at 17,155 shares worth $539K. The position accounts for 0.14% of the portfolio, ranked #63.

Kings Path Partners first reported a position in PAHC in Q1 2025 and has held it in 6 quarters since. The position peaked at $694K in Q3 2025. 19 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Kings Path Partners held 17,155 shares of Phibro Animal Health worth $539K as of Q2 2026.
  • Kings Path Partners left its Phibro Animal Health share count unchanged in Q2 2026.
  • Phibro Animal Health made up 0.14% of Kings Path Partners's portfolio in Q2 2026, its #63 holding.
  • Kings Path Partners first reported a position in Phibro Animal Health in Q1 2025 and has held it in 6 quarters since.
  • Kings Path Partners's Phibro Animal Health position peaked at $694K in Q3 2025.
  • 19 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Kings Path Partners's 13F filing for Q2 2026, filed 14 Jul 2026.